These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

294 related items for PubMed ID: 20649880

  • 1. Immunoglobulin A1 protease: a new therapeutic candidate for immunoglobulin A nephropathy.
    Xie LS, Huang J, Qin W, Fan JM.
    Nephrology (Carlton); 2010 Aug; 15(5):584-6. PubMed ID: 20649880
    [Abstract] [Full Text] [Related]

  • 2. Engagement of transferrin receptor by polymeric IgA1: evidence for a positive feedback loop involving increased receptor expression and mesangial cell proliferation in IgA nephropathy.
    Moura IC, Arcos-Fajardo M, Gdoura A, Leroy V, Sadaka C, Mahlaoui N, Lepelletier Y, Vrtovsnik F, Haddad E, Benhamou M, Monteiro RC.
    J Am Soc Nephrol; 2005 Sep; 16(9):2667-76. PubMed ID: 15987753
    [Abstract] [Full Text] [Related]

  • 3. Binding capacity and pathophysiological effects of IgA1 from patients with IgA nephropathy on human glomerular mesangial cells.
    Wang Y, Zhao MH, Zhang YK, Li XM, Wang HY.
    Clin Exp Immunol; 2004 Apr; 136(1):168-75. PubMed ID: 15030528
    [Abstract] [Full Text] [Related]

  • 4. New insights in the pathogenesis of IgA nephropathy.
    Monteiro RC.
    Nefrologia; 2005 Apr; 25 Suppl 2():82-6. PubMed ID: 16050408
    [Abstract] [Full Text] [Related]

  • 5. IgA1 Protease Treatment Reverses Mesangial Deposits and Hematuria in a Model of IgA Nephropathy.
    Lechner SM, Abbad L, Boedec E, Papista C, Le Stang MB, Moal C, Maillard J, Jamin A, Bex-Coudrat J, Wang Y, Li A, Martini PG, Monteiro RC, Berthelot L.
    J Am Soc Nephrol; 2016 Sep; 27(9):2622-9. PubMed ID: 26850635
    [Abstract] [Full Text] [Related]

  • 6. Mesangial IgA2 deposits and lectin pathway-mediated complement activation in IgA glomerulonephritis.
    Hisano S, Matsushita M, Fujita T, Endo Y, Takebayashi S.
    Am J Kidney Dis; 2001 Nov; 38(5):1082-8. PubMed ID: 11684563
    [Abstract] [Full Text] [Related]

  • 7. Integrin α1/β1 and α2/β1 as a receptor for IgA1 in human glomerular mesangial cells in IgA nephropathy.
    Kaneko Y, Otsuka T, Tsuchida Y, Gejyo F, Narita I.
    Int Immunol; 2012 Apr; 24(4):219-32. PubMed ID: 22298882
    [Abstract] [Full Text] [Related]

  • 8. [Progress in understanding the pathogenesis of IgA nephropathy: new perspectives for the near future?].
    Segarra A.
    Nefrologia; 2010 Apr; 30(5):501-7. PubMed ID: 20882091
    [Abstract] [Full Text] [Related]

  • 9. Oxidative stress in IgA nephropathy.
    Coppo R, Camilla R, Amore A, Peruzzi L.
    Nephron Clin Pract; 2010 Apr; 116(3):c196-8, discussion c199. PubMed ID: 20606479
    [Abstract] [Full Text] [Related]

  • 10. Aberrant glycosylation of IgA1 and anti-glycan antibodies in IgA nephropathy: role of mucosal immune system.
    Novak J, Moldoveanu Z, Julian BA, Raska M, Wyatt RJ, Suzuki Y, Tomino Y, Gharavi AG, Mestecky J, Suzuki H.
    Adv Otorhinolaryngol; 2011 Apr; 72():60-3. PubMed ID: 21865691
    [Abstract] [Full Text] [Related]

  • 11. Immunopathogenetic aspects of IgA nephropathy.
    van den Wall Bake AW, Daha MR, van Es LA.
    Nephrologie; 1989 Apr; 10(3):141-5. PubMed ID: 2691911
    [Abstract] [Full Text] [Related]

  • 12. IgA nephropathy: an update.
    Julian BA, Novak J.
    Curr Opin Nephrol Hypertens; 2004 Mar; 13(2):171-9. PubMed ID: 15202611
    [Abstract] [Full Text] [Related]

  • 13. Role of complement in IgA nephropathy.
    Daha MR, van Kooten C.
    J Nephrol; 2016 Feb; 29(1):1-4. PubMed ID: 26567162
    [Abstract] [Full Text] [Related]

  • 14. Structural features of IgA molecules which contribute to IgA nephropathy.
    Feehally J, Allen AC.
    J Nephrol; 1999 Feb; 12(2):59-65. PubMed ID: 10378660
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Immunopathogenesis of IgAN.
    Barratt J, Smith AC, Molyneux K, Feehally J.
    Semin Immunopathol; 2007 Nov; 29(4):427-43. PubMed ID: 17851660
    [Abstract] [Full Text] [Related]

  • 17. The bone marrow as a possible origin of the IgA1 deposited in the mesangium in IgA nephropathy.
    van den Wall Bake AW, Daha MR, Valentijn RM, van Es LA.
    Semin Nephrol; 1987 Dec; 7(4):329-31. PubMed ID: 3445010
    [No Abstract] [Full Text] [Related]

  • 18. The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy.
    Tamouza H, Chemouny JM, Raskova Kafkova L, Berthelot L, Flamant M, Demion M, Mesnard L, Paubelle E, Walker F, Julian BA, Tissandié E, Tiwari MK, Camara NO, Vrtovsnik F, Benhamou M, Novak J, Monteiro RC, Moura IC.
    Kidney Int; 2012 Dec; 82(12):1284-96. PubMed ID: 22951891
    [Abstract] [Full Text] [Related]

  • 19. Microbial IgA protease removes IgA immune complexes from mouse glomeruli in vivo: potential therapy for IgA nephropathy.
    Lamm ME, Emancipator SN, Robinson JK, Yamashita M, Fujioka H, Qiu J, Plaut AG.
    Am J Pathol; 2008 Jan; 172(1):31-6. PubMed ID: 18165266
    [Abstract] [Full Text] [Related]

  • 20. Immune characteristics of renal allograft donors with mesangial IgA deposition.
    Wang Z, Zhang X, Han W, Yu G, Ying Z, Xu X, Wang M, Zhou X, Lv J, Zhang H.
    Int Immunopharmacol; 2021 Feb; 91():107282. PubMed ID: 33370682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.